Ligand validation:4MBK

MA4: CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE

MA4 is a Ligand Of Interest in 4MBK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4MBK_MA4_A_301	74%	55%	0.089	0.919	0.63	1.09	1	4	1	0	100%	1
4MBK_MA4_A_302	12%	61%	0.165	0.831	0.37	1.12	-	2	0	0	23%	0.2286
1N9B_MA4_A_300	97%	57%	0.062	0.979	0.68	0.97	-	4	0	0	100%	0.8491
4FH4_MA4_A_301	95%	46%	0.069	0.973	0.88	1.19	2	4	0	0	100%	1
2ZD8_MA4_A_301	91%	41%	0.08	0.967	0.8	1.47	1	7	0	0	100%	1
1ONG_MA4_A_300	91%	53%	0.079	0.964	0.78	1.02	1	3	1	0	100%	0.824
4FCF_MA4_A_301	89%	58%	0.083	0.962	0.55	1.06	-	3	1	0	100%	1
4MBF_MA4_A_301	88%	52%	0.069	0.944	0.79	1.05	1	3	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.